Contravisory Investment Management, Inc. Edgewise Therapeutics, Inc. Transaction History
Contravisory Investment Management, Inc.
- $450 Million
- Q1 2025
A detailed history of Contravisory Investment Management, Inc. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 10,209 shares of EWTX stock, worth $145,784. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,209Holding current value
$145,784% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$215 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$127 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$93.5 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$87.9 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$85.9 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $902M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...